Article | July 25, 2017

Autologous Cell Therapies At A Crossroads With The FDA: What Can You Do to Help?

Source: Finesse, part of Thermo Fisher Scientific

Autologous Cell Therapies At A Crossroads With The FDA: What Can You Do to Help?

One area of great interest concerns the use of a patient’s own cells to treat the disease they are suffering from, which is also known as autologous cell therapy. The ability to administer stem cell therapies at the bedside would facilitate and expedite treatment, translating to an even more remarkable impact on some of the world’s most affected patient populations.

Finesse, part of Thermo Fisher Scientific